Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

NCT01694485 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
359
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen